From the Food and Drug Administration. | JAMA;281(21): 1978, 1999 Jun 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

From the Food and Drug Administration.

Nightingale, S L.

JAMA ; 281(21): 1978, 1999 Jun 02.

Article in En | MEDLINE | ID: mdl-10359372

Subject(s)

Anti-Obesity Agents; Blood Transfusion/instrumentation; Hypotension/etiology; Lactones; Leukapheresis/instrumentation; Lipase/antagonists & inhibitors; Drug Approval; Equipment Failure; Humans; Leukapheresis/adverse effects; Orlistat; Product Surveillance, Postmarketing; Transfusion Reaction; United States; United States Food and Drug Administration

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Leukapheresis / Anti-Obesity Agents / Hypotension / Lactones / Lipase Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Year: 1999 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Blood Transfusion / Leukapheresis / Anti-Obesity Agents / Hypotension / Lactones / Lipase Limits: Humans Country/Region as subject: America do norte Language: En Journal: JAMA Year: 1999 Document type: Article Country of publication: United States